Previous close | 518.60 |
Open | 518.60 |
Bid | 513.40 x 10000 |
Ask | 515.60 x 10000 |
Day's range | 518.60 - 518.60 |
52-week range | 355.00 - 526.60 |
Volume | |
Avg. volume | 10 |
Market cap | 67.411B |
Beta (5Y monthly) | 0.45 |
PE ratio (TTM) | 24.93 |
EPS (TTM) | 20.80 |
Earnings date | 31 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | 2.33 (0.45%) |
Ex-dividend date | 03 Jun 2024 |
1y target est | 240.38 |
Investors in McKesson Corporation ( NYSE:MCK ) had a good week, as its shares rose 2.4% to close at US$544 following...
McKesson's (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical Solutions segment.
McKesson Corporation (NYSE:MCK) Q4 2024 Earnings Call Transcript May 7, 2024 McKesson Corporation misses on earnings expectations. Reported EPS is $6.18 EPS, expectations were $6.36. McKesson Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Please stand by. Welcome to […]